1. Home
  2. OLMA vs DFP Comparison

OLMA vs DFP Comparison

Compare OLMA & DFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • DFP
  • Stock Information
  • Founded
  • OLMA 2006
  • DFP 2013
  • Country
  • OLMA United States
  • DFP United States
  • Employees
  • OLMA N/A
  • DFP N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • DFP Investment Managers
  • Sector
  • OLMA Health Care
  • DFP Finance
  • Exchange
  • OLMA Nasdaq
  • DFP Nasdaq
  • Market Cap
  • OLMA 420.2M
  • DFP 418.2M
  • IPO Year
  • OLMA 2020
  • DFP N/A
  • Fundamental
  • Price
  • OLMA $5.66
  • DFP $20.39
  • Analyst Decision
  • OLMA Strong Buy
  • DFP
  • Analyst Count
  • OLMA 5
  • DFP 0
  • Target Price
  • OLMA $26.25
  • DFP N/A
  • AVG Volume (30 Days)
  • OLMA 1.3M
  • DFP 56.2K
  • Earning Date
  • OLMA 03-10-2025
  • DFP 01-01-0001
  • Dividend Yield
  • OLMA N/A
  • DFP 6.73%
  • EPS Growth
  • OLMA N/A
  • DFP N/A
  • EPS
  • OLMA N/A
  • DFP N/A
  • Revenue
  • OLMA N/A
  • DFP N/A
  • Revenue This Year
  • OLMA N/A
  • DFP N/A
  • Revenue Next Year
  • OLMA N/A
  • DFP N/A
  • P/E Ratio
  • OLMA N/A
  • DFP N/A
  • Revenue Growth
  • OLMA N/A
  • DFP N/A
  • 52 Week Low
  • OLMA $4.60
  • DFP $15.45
  • 52 Week High
  • OLMA $16.78
  • DFP $19.31
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 41.95
  • DFP 54.99
  • Support Level
  • OLMA $4.60
  • DFP $19.85
  • Resistance Level
  • OLMA $5.83
  • DFP $20.45
  • Average True Range (ATR)
  • OLMA 0.54
  • DFP 0.22
  • MACD
  • OLMA 0.15
  • DFP 0.05
  • Stochastic Oscillator
  • OLMA 59.55
  • DFP 85.54

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.

Flaherty & Crumrine Pref&Inc Allocation is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.

Share on Social Networks: